Table of Content

1 Human Granulocyte Colony-stimulating Factor Market Overview
1.1 Human Granulocyte Colony-stimulating Factor Product Scope
1.2 Human Granulocyte Colony-stimulating Factor Segment by Type
1.2.1 Global Human Granulocyte Colony-stimulating Factor Sales by Type (2016 & 2021 & 2027)
1.2.2 300μg/Dose
1.2.3 150μg/Dose
1.2.4 75μg/Dose
1.2.5 Others
1.3 Human Granulocyte Colony-stimulating Factor Segment by Application
1.3.1 Global Human Granulocyte Colony-stimulating Factor Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hospital
1.3.3 Clinic
1.4 Human Granulocyte Colony-stimulating Factor Market Estimates and Forecasts (2016-2027)
1.4.1 Global Human Granulocyte Colony-stimulating Factor Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Human Granulocyte Colony-stimulating Factor Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Human Granulocyte Colony-stimulating Factor Price Trends (2016-2027)

2 Human Granulocyte Colony-stimulating Factor Estimates and Forecasts by Region
2.1 Global Human Granulocyte Colony-stimulating Factor Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Human Granulocyte Colony-stimulating Factor Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Human Granulocyte Colony-stimulating Factor Sales Market Share by Region (2016-2021)
2.2.2 Global Human Granulocyte Colony-stimulating Factor Revenue Market Share by Region (2016-2021)
2.3 Global Human Granulocyte Colony-stimulating Factor Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Human Granulocyte Colony-stimulating Factor Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Human Granulocyte Colony-stimulating Factor Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Human Granulocyte Colony-stimulating Factor Estimates and Projections (2016-2027)
2.4.2 Europe Human Granulocyte Colony-stimulating Factor Estimates and Projections (2016-2027)
2.4.3 China Human Granulocyte Colony-stimulating Factor Estimates and Projections (2016-2027)
2.4.4 Japan Human Granulocyte Colony-stimulating Factor Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Human Granulocyte Colony-stimulating Factor Estimates and Projections (2016-2027)
2.4.6 India Human Granulocyte Colony-stimulating Factor Estimates and Projections (2016-2027)

3 Global Human Granulocyte Colony-stimulating Factor Competition Landscape by Players
3.1 Global Top Human Granulocyte Colony-stimulating Factor Players by Sales (2016-2021)
3.2 Global Top Human Granulocyte Colony-stimulating Factor Players by Revenue (2016-2021)
3.3 Global Human Granulocyte Colony-stimulating Factor Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Granulocyte Colony-stimulating Factor as of 2020)
3.4 Global Human Granulocyte Colony-stimulating Factor Average Price by Company (2016-2021)
3.5 Manufacturers Human Granulocyte Colony-stimulating Factor Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Human Granulocyte Colony-stimulating Factor Market Size by Type
4.1 Global Human Granulocyte Colony-stimulating Factor Historic Market Review by Type (2016-2021)
4.1.1 Global Human Granulocyte Colony-stimulating Factor Sales Market Share by Type (2016-2021)
4.1.2 Global Human Granulocyte Colony-stimulating Factor Revenue Market Share by Type (2016-2021)
4.1.3 Global Human Granulocyte Colony-stimulating Factor Price by Type (2016-2021)
4.2 Global Human Granulocyte Colony-stimulating Factor Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Human Granulocyte Colony-stimulating Factor Sales Forecast by Type (2022-2027)
4.2.2 Global Human Granulocyte Colony-stimulating Factor Revenue Forecast by Type (2022-2027)
4.2.3 Global Human Granulocyte Colony-stimulating Factor Price Forecast by Type (2022-2027)

5 Global Human Granulocyte Colony-stimulating Factor Market Size by Application
5.1 Global Human Granulocyte Colony-stimulating Factor Historic Market Review by Application (2016-2021)
5.1.1 Global Human Granulocyte Colony-stimulating Factor Sales Market Share by Application (2016-2021)
5.1.2 Global Human Granulocyte Colony-stimulating Factor Revenue Market Share by Application (2016-2021)
5.1.3 Global Human Granulocyte Colony-stimulating Factor Price by Application (2016-2021)
5.2 Global Human Granulocyte Colony-stimulating Factor Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Human Granulocyte Colony-stimulating Factor Sales Forecast by Application (2022-2027)
5.2.2 Global Human Granulocyte Colony-stimulating Factor Revenue Forecast by Application (2022-2027)
5.2.3 Global Human Granulocyte Colony-stimulating Factor Price Forecast by Application (2022-2027)

6 North America Human Granulocyte Colony-stimulating Factor Market Facts & Figures
6.1 North America Human Granulocyte Colony-stimulating Factor Sales by Company
6.1.1 North America Human Granulocyte Colony-stimulating Factor Sales by Company (2016-2021)
6.1.2 North America Human Granulocyte Colony-stimulating Factor Revenue by Company (2016-2021)
6.2 North America Human Granulocyte Colony-stimulating Factor Sales Breakdown by Type
6.2.1 North America Human Granulocyte Colony-stimulating Factor Sales Breakdown by Type (2016-2021)
6.2.2 North America Human Granulocyte Colony-stimulating Factor Sales Breakdown by Type (2022-2027)
6.3 North America Human Granulocyte Colony-stimulating Factor Sales Breakdown by Application
6.3.1 North America Human Granulocyte Colony-stimulating Factor Sales Breakdown by Application (2016-2021)
6.3.2 North America Human Granulocyte Colony-stimulating Factor Sales Breakdown by Application (2022-2027)

7 Europe Human Granulocyte Colony-stimulating Factor Market Facts & Figures
7.1 Europe Human Granulocyte Colony-stimulating Factor Sales by Company
7.1.1 Europe Human Granulocyte Colony-stimulating Factor Sales by Company (2016-2021)
7.1.2 Europe Human Granulocyte Colony-stimulating Factor Revenue by Company (2016-2021)
7.2 Europe Human Granulocyte Colony-stimulating Factor Sales Breakdown by Type
7.2.1 Europe Human Granulocyte Colony-stimulating Factor Sales Breakdown by Type (2016-2021)
7.2.2 Europe Human Granulocyte Colony-stimulating Factor Sales Breakdown by Type (2022-2027)
7.3 Europe Human Granulocyte Colony-stimulating Factor Sales Breakdown by Application
7.3.1 Europe 142 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 142 Sales Breakdown by Application (2022-2027)

8 China Human Granulocyte Colony-stimulating Factor Market Facts & Figures
8.1 China Human Granulocyte Colony-stimulating Factor Sales by Company
8.1.1 China Human Granulocyte Colony-stimulating Factor Sales by Company (2016-2021)
8.1.2 China Human Granulocyte Colony-stimulating Factor Revenue by Company (2016-2021)
8.2 China Human Granulocyte Colony-stimulating Factor Sales Breakdown by Type
8.2.1 China Human Granulocyte Colony-stimulating Factor Sales Breakdown by Type (2016-2021)
8.2.2 China Human Granulocyte Colony-stimulating Factor Sales Breakdown by Type (2022-2027)
8.3 China Human Granulocyte Colony-stimulating Factor Sales Breakdown by Application
8.3.1 China 166 Sales Breakdown by Application (2016-2021)
8.3.2 China 166 Sales Breakdown by Application (2022-2027)

9 Japan Human Granulocyte Colony-stimulating Factor Market Facts & Figures
9.1 Japan Human Granulocyte Colony-stimulating Factor Sales by Company
9.1.1 Japan Human Granulocyte Colony-stimulating Factor Sales by Company (2016-2021)
9.1.2 Japan Human Granulocyte Colony-stimulating Factor Revenue by Company (2016-2021)
9.2 Japan Human Granulocyte Colony-stimulating Factor Sales Breakdown by Type
9.2.1 Japan Human Granulocyte Colony-stimulating Factor Sales Breakdown by Type (2016-2021)
9.2.2 Japan Human Granulocyte Colony-stimulating Factor Sales Breakdown by Type (2022-2027)
9.3 Japan Human Granulocyte Colony-stimulating Factor Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Human Granulocyte Colony-stimulating Factor Market Facts & Figures
10.1 Southeast Asia Human Granulocyte Colony-stimulating Factor Sales by Company
10.1.1 Southeast Asia Human Granulocyte Colony-stimulating Factor Sales by Company (2016-2021)
10.1.2 Southeast Asia Human Granulocyte Colony-stimulating Factor Revenue by Company (2016-2021)
10.2 Southeast Asia Human Granulocyte Colony-stimulating Factor Sales Breakdown by Type
10.2.1 Southeast Asia Human Granulocyte Colony-stimulating Factor Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Human Granulocyte Colony-stimulating Factor Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Human Granulocyte Colony-stimulating Factor Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Human Granulocyte Colony-stimulating Factor Market Facts & Figures
11.1 India Human Granulocyte Colony-stimulating Factor Sales by Company
11.1.1 India Human Granulocyte Colony-stimulating Factor Sales by Company (2016-2021)
11.1.2 India Human Granulocyte Colony-stimulating Factor Revenue by Company (2016-2021)
11.2 India Human Granulocyte Colony-stimulating Factor Sales Breakdown by Type
11.2.1 India Human Granulocyte Colony-stimulating Factor Sales Breakdown by Type (2016-2021)
11.2.2 India Human Granulocyte Colony-stimulating Factor Sales Breakdown by Type (2022-2027)
11.3 India Human Granulocyte Colony-stimulating Factor Sales Breakdown by Application
11.3.1 India Human Granulocyte Colony-stimulating Factor Sales Breakdown by Application (2016-2021)
11.3.2 India Human Granulocyte Colony-stimulating Factor Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Human Granulocyte Colony-stimulating Factor Business
12.1 Chugai Pharmaceutical
12.1.1 Chugai Pharmaceutical Corporation Information
12.1.2 Chugai Pharmaceutical Business Overview
12.1.3 Chugai Pharmaceutical Human Granulocyte Colony-stimulating Factor Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Chugai Pharmaceutical Human Granulocyte Colony-stimulating Factor Products Offered
12.1.5 Chugai Pharmaceutical Recent Development
12.2 Kyowa Hakko Kirin
12.2.1 Kyowa Hakko Kirin Corporation Information
12.2.2 Kyowa Hakko Kirin Business Overview
12.2.3 Kyowa Hakko Kirin Human Granulocyte Colony-stimulating Factor Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Kyowa Hakko Kirin Human Granulocyte Colony-stimulating Factor Products Offered
12.2.5 Kyowa Hakko Kirin Recent Development
12.3 Sanway
12.3.1 Sanway Corporation Information
12.3.2 Sanway Business Overview
12.3.3 Sanway Human Granulocyte Colony-stimulating Factor Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Sanway Human Granulocyte Colony-stimulating Factor Products Offered
12.3.5 Sanway Recent Development
12.4 GenSci
12.4.1 GenSci Corporation Information
12.4.2 GenSci Business Overview
12.4.3 GenSci Human Granulocyte Colony-stimulating Factor Sales, Revenue and Gross Margin (2016-2021)
12.4.4 GenSci Human Granulocyte Colony-stimulating Factor Products Offered
12.4.5 GenSci Recent Development
12.5 SL PHARM
12.5.1 SL PHARM Corporation Information
12.5.2 SL PHARM Business Overview
12.5.3 SL PHARM Human Granulocyte Colony-stimulating Factor Sales, Revenue and Gross Margin (2016-2021)
12.5.4 SL PHARM Human Granulocyte Colony-stimulating Factor Products Offered
12.5.5 SL PHARM Recent Development
12.6 Kexing Bioproducts
12.6.1 Kexing Bioproducts Corporation Information
12.6.2 Kexing Bioproducts Business Overview
12.6.3 Kexing Bioproducts Human Granulocyte Colony-stimulating Factor Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Kexing Bioproducts Human Granulocyte Colony-stimulating Factor Products Offered
12.6.5 Kexing Bioproducts Recent Development
12.7 Qilu Pharmaceutical
12.7.1 Qilu Pharmaceutical Corporation Information
12.7.2 Qilu Pharmaceutical Business Overview
12.7.3 Qilu Pharmaceutical Human Granulocyte Colony-stimulating Factor Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Qilu Pharmaceutical Human Granulocyte Colony-stimulating Factor Products Offered
12.7.5 Qilu Pharmaceutical Recent Development
12.8 CSPC
12.8.1 CSPC Corporation Information
12.8.2 CSPC Business Overview
12.8.3 CSPC Human Granulocyte Colony-stimulating Factor Sales, Revenue and Gross Margin (2016-2021)
12.8.4 CSPC Human Granulocyte Colony-stimulating Factor Products Offered
12.8.5 CSPC Recent Development
12.9 Wuzhong Pharmaceutical
12.9.1 Wuzhong Pharmaceutical Corporation Information
12.9.2 Wuzhong Pharmaceutical Business Overview
12.9.3 Wuzhong Pharmaceutical Human Granulocyte Colony-stimulating Factor Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Wuzhong Pharmaceutical Human Granulocyte Colony-stimulating Factor Products Offered
12.9.5 Wuzhong Pharmaceutical Recent Development
12.10 Quangang Pharmaceutical
12.10.1 Quangang Pharmaceutical Corporation Information
12.10.2 Quangang Pharmaceutical Business Overview
12.10.3 Quangang Pharmaceutical Human Granulocyte Colony-stimulating Factor Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Quangang Pharmaceutical Human Granulocyte Colony-stimulating Factor Products Offered
12.10.5 Quangang Pharmaceutical Recent Development
12.11 Huabei Pharmaceutical
12.11.1 Huabei Pharmaceutical Corporation Information
12.11.2 Huabei Pharmaceutical Business Overview
12.11.3 Huabei Pharmaceutical Human Granulocyte Colony-stimulating Factor Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Huabei Pharmaceutical Human Granulocyte Colony-stimulating Factor Products Offered
12.11.5 Huabei Pharmaceutical Recent Development
12.12 Harbin Pharmaceutical
12.12.1 Harbin Pharmaceutical Corporation Information
12.12.2 Harbin Pharmaceutical Business Overview
12.12.3 Harbin Pharmaceutical Human Granulocyte Colony-stimulating Factor Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Harbin Pharmaceutical Human Granulocyte Colony-stimulating Factor Products Offered
12.12.5 Harbin Pharmaceutical Recent Development
12.13 Amoytop Biotech
12.13.1 Amoytop Biotech Corporation Information
12.13.2 Amoytop Biotech Business Overview
12.13.3 Amoytop Biotech Human Granulocyte Colony-stimulating Factor Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Amoytop Biotech Human Granulocyte Colony-stimulating Factor Products Offered
12.13.5 Amoytop Biotech Recent Development
12.14 Jiuyuan Gene Engineering
12.14.1 Jiuyuan Gene Engineering Corporation Information
12.14.2 Jiuyuan Gene Engineering Business Overview
12.14.3 Jiuyuan Gene Engineering Human Granulocyte Colony-stimulating Factor Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Jiuyuan Gene Engineering Human Granulocyte Colony-stimulating Factor Products Offered
12.14.5 Jiuyuan Gene Engineering Recent Development
12.15 Four Rings Biopharmaceutical
12.15.1 Four Rings Biopharmaceutical Corporation Information
12.15.2 Four Rings Biopharmaceutical Business Overview
12.15.3 Four Rings Biopharmaceutical Human Granulocyte Colony-stimulating Factor Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Four Rings Biopharmaceutical Human Granulocyte Colony-stimulating Factor Products Offered
12.15.5 Four Rings Biopharmaceutical Recent Development

13 Human Granulocyte Colony-stimulating Factor Manufacturing Cost Analysis
13.1 Human Granulocyte Colony-stimulating Factor Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Human Granulocyte Colony-stimulating Factor
13.4 Human Granulocyte Colony-stimulating Factor Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Human Granulocyte Colony-stimulating Factor Distributors List
14.3 Human Granulocyte Colony-stimulating Factor Customers

15 Market Dynamics
15.1 Human Granulocyte Colony-stimulating Factor Market Trends
15.2 Human Granulocyte Colony-stimulating Factor Drivers
15.3 Human Granulocyte Colony-stimulating Factor Market Challenges
15.4 Human Granulocyte Colony-stimulating Factor Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Human Granulocyte Colony-stimulating Factor Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Human Granulocyte Colony-stimulating Factor Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Human Granulocyte Colony-stimulating Factor Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Human Granulocyte Colony-stimulating Factor Sales (K Units) by Region (2016-2021)
Table 5. Global Human Granulocyte Colony-stimulating Factor Sales Market Share by Region (2016-2021)
Table 6. Global Human Granulocyte Colony-stimulating Factor Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Human Granulocyte Colony-stimulating Factor Revenue Share by Region (2016-2021)
Table 8. Global Human Granulocyte Colony-stimulating Factor Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Human Granulocyte Colony-stimulating Factor Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Human Granulocyte Colony-stimulating Factor Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Human Granulocyte Colony-stimulating Factor Revenue Share Forecast by Region (2022-2027)
Table 12. Global Human Granulocyte Colony-stimulating Factor Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Human Granulocyte Colony-stimulating Factor Sales Share by Company (2016-2021)
Table 14. Global Human Granulocyte Colony-stimulating Factor Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Human Granulocyte Colony-stimulating Factor Revenue Share by Company (2016-2021)
Table 16. Global Human Granulocyte Colony-stimulating Factor by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Granulocyte Colony-stimulating Factor as of 2020)
Table 17. Global Human Granulocyte Colony-stimulating Factor Average Price (US$/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Human Granulocyte Colony-stimulating Factor Manufacturing Sites and Area Served
Table 19. Manufacturers Human Granulocyte Colony-stimulating Factor Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Human Granulocyte Colony-stimulating Factor Sales (K Units) by Type (2016-2021)
Table 22. Global Human Granulocyte Colony-stimulating Factor Sales Share by Type (2016-2021)
Table 23. Global Human Granulocyte Colony-stimulating Factor Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Human Granulocyte Colony-stimulating Factor Price (US$/Unit) by Type (2016-2021)
Table 25. Global Human Granulocyte Colony-stimulating Factor Sales Share by Type (2022-2027)
Table 26. Global Human Granulocyte Colony-stimulating Factor Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Human Granulocyte Colony-stimulating Factor Revenue Share by Type (2022-2027)
Table 28. Global Human Granulocyte Colony-stimulating Factor Price (US$/Unit) by Type (2022-2027)
Table 29. Global Human Granulocyte Colony-stimulating Factor Sales (K Units) by Application (2016-2021)
Table 30. Global Human Granulocyte Colony-stimulating Factor Sales Share by Application (2016-2021)
Table 31. Global Human Granulocyte Colony-stimulating Factor Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Human Granulocyte Colony-stimulating Factor Price (US$/Unit) by Application (2016-2021)
Table 33. Global Human Granulocyte Colony-stimulating Factor Sales (K Units) by Application (2022-2027)
Table 34. Global Human Granulocyte Colony-stimulating Factor Sales Share by Application (2022-2027)
Table 35. Global Human Granulocyte Colony-stimulating Factor Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Human Granulocyte Colony-stimulating Factor Revenue Share by Application (2022-2027)
Table 37. Global Human Granulocyte Colony-stimulating Factor Price (US$/Unit) by Application (2022-2027)
Table 38. North America Human Granulocyte Colony-stimulating Factor Sales (K Units) by Company (2016-2021)
Table 39. North America Human Granulocyte Colony-stimulating Factor Sales Market Share by Company (2016-2021)
Table 40. North America Human Granulocyte Colony-stimulating Factor Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Human Granulocyte Colony-stimulating Factor Revenue Market Share by Company (2016-2021)
Table 42. North America Human Granulocyte Colony-stimulating Factor Sales by Type (2016-2021) & (K Units)
Table 43. North America Human Granulocyte Colony-stimulating Factor Sales Market Share by Type (2016-2021)
Table 44. North America Human Granulocyte Colony-stimulating Factor Sales by Type (2022-2027) & (K Units)
Table 45. North America Human Granulocyte Colony-stimulating Factor Sales Market Share by Type (2022-2027)
Table 46. North America Human Granulocyte Colony-stimulating Factor Sales by Application (2016-2021) & (K Units)
Table 47. North America Human Granulocyte Colony-stimulating Factor Sales Market Share by Application (2016-2021)
Table 48. North America Human Granulocyte Colony-stimulating Factor Sales by Application (2022-2027) & (K Units)
Table 49. North America Human Granulocyte Colony-stimulating Factor Sales Market Share by Application (2022-2027)
Table 50. Europe Human Granulocyte Colony-stimulating Factor Sales (K Units) by Company (2016-2021)
Table 51. Europe Human Granulocyte Colony-stimulating Factor Sales Market Share by Company (2016-2021)
Table 52. Europe Human Granulocyte Colony-stimulating Factor Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Human Granulocyte Colony-stimulating Factor Revenue Market Share by Company (2016-2021)
Table 54. Europe Human Granulocyte Colony-stimulating Factor Sales by Type (2016-2021) & (K Units)
Table 55. Europe Human Granulocyte Colony-stimulating Factor Sales Market Share by Type (2016-2021)
Table 56. Europe Human Granulocyte Colony-stimulating Factor Sales by Type (2022-2027) & (K Units)
Table 57. Europe Human Granulocyte Colony-stimulating Factor Sales Market Share by Type (2022-2027)
Table 58. Europe Human Granulocyte Colony-stimulating Factor Sales by Application (2016-2021) & (K Units)
Table 59. Europe Human Granulocyte Colony-stimulating Factor Sales Market Share by Application (2016-2021)
Table 60. Europe Human Granulocyte Colony-stimulating Factor Sales by Application (2022-2027) & (K Units)
Table 61. Europe Human Granulocyte Colony-stimulating Factor Sales Market Share by Application (2022-2027)
Table 62. China Human Granulocyte Colony-stimulating Factor Sales (K Units) by Company (2016-2021)
Table 63. China Human Granulocyte Colony-stimulating Factor Sales Market Share by Company (2016-2021)
Table 64. China Human Granulocyte Colony-stimulating Factor Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Human Granulocyte Colony-stimulating Factor Revenue Market Share by Company (2016-2021)
Table 66. China Human Granulocyte Colony-stimulating Factor Sales by Type (2016-2021) & (K Units)
Table 67. China Human Granulocyte Colony-stimulating Factor Sales Market Share by Type (2016-2021)
Table 68. China Human Granulocyte Colony-stimulating Factor Sales by Type (2022-2027) & (K Units)
Table 69. China Human Granulocyte Colony-stimulating Factor Sales Market Share by Type (2022-2027)
Table 70. China Human Granulocyte Colony-stimulating Factor Sales by Application (2016-2021) & (K Units)
Table 71. China Human Granulocyte Colony-stimulating Factor Sales Market Share by Application (2016-2021)
Table 72. China Human Granulocyte Colony-stimulating Factor Sales by Application (2022-2027) & (K Units)
Table 73. China Human Granulocyte Colony-stimulating Factor Sales Market Share by Application (2022-2027)
Table 74. Japan Human Granulocyte Colony-stimulating Factor Sales (K Units) by Company (2016-2021)
Table 75. Japan Human Granulocyte Colony-stimulating Factor Sales Market Share by Company (2016-2021)
Table 76. Japan Human Granulocyte Colony-stimulating Factor Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Human Granulocyte Colony-stimulating Factor Revenue Market Share by Company (2016-2021)
Table 78. Japan Human Granulocyte Colony-stimulating Factor Sales by Type (2016-2021) & (K Units)
Table 79. Japan Human Granulocyte Colony-stimulating Factor Sales Market Share by Type (2016-2021)
Table 80. Japan Human Granulocyte Colony-stimulating Factor Sales by Type (2022-2027) & (K Units)
Table 81. Japan Human Granulocyte Colony-stimulating Factor Sales Market Share by Type (2022-2027)
Table 82. Japan Human Granulocyte Colony-stimulating Factor Sales by Application (2016-2021) & (K Units)
Table 83. Japan Human Granulocyte Colony-stimulating Factor Sales Market Share by Application (2016-2021)
Table 84. Japan Human Granulocyte Colony-stimulating Factor Sales by Application (2022-2027) & (K Units)
Table 85. Japan Human Granulocyte Colony-stimulating Factor Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Human Granulocyte Colony-stimulating Factor Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Human Granulocyte Colony-stimulating Factor Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Human Granulocyte Colony-stimulating Factor Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Human Granulocyte Colony-stimulating Factor Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Human Granulocyte Colony-stimulating Factor Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Human Granulocyte Colony-stimulating Factor Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Human Granulocyte Colony-stimulating Factor Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Human Granulocyte Colony-stimulating Factor Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Human Granulocyte Colony-stimulating Factor Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Human Granulocyte Colony-stimulating Factor Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Human Granulocyte Colony-stimulating Factor Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Human Granulocyte Colony-stimulating Factor Sales Market Share by Application (2022-2027)
Table 98. India Human Granulocyte Colony-stimulating Factor Sales (K Units) by Company (2016-2021)
Table 99. India Human Granulocyte Colony-stimulating Factor Sales Market Share by Company (2016-2021)
Table 100. India Human Granulocyte Colony-stimulating Factor Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Human Granulocyte Colony-stimulating Factor Revenue Market Share by Company (2016-2021)
Table 102. India Human Granulocyte Colony-stimulating Factor Sales by Type (2016-2021) & (K Units)
Table 103. India Human Granulocyte Colony-stimulating Factor Sales Market Share by Type (2016-2021)
Table 104. India Human Granulocyte Colony-stimulating Factor Sales by Type (2022-2027) & (K Units)
Table 105. India Human Granulocyte Colony-stimulating Factor Sales Market Share by Type (2022-2027)
Table 106. India Human Granulocyte Colony-stimulating Factor Sales by Application (2016-2021) & (K Units)
Table 107. India Human Granulocyte Colony-stimulating Factor Sales Market Share by Application (2016-2021)
Table 108. India Human Granulocyte Colony-stimulating Factor Sales by Application (2022-2027) & (K Units)
Table 109. India Human Granulocyte Colony-stimulating Factor Sales Market Share by Application (2022-2027)
Table 110. Chugai Pharmaceutical Corporation Information
Table 111. Chugai Pharmaceutical Description and Business Overview
Table 112. Chugai Pharmaceutical Human Granulocyte Colony-stimulating Factor Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 113. Chugai Pharmaceutical Human Granulocyte Colony-stimulating Factor Product
Table 114. Chugai Pharmaceutical Recent Development
Table 115. Kyowa Hakko Kirin Corporation Information
Table 116. Kyowa Hakko Kirin Description and Business Overview
Table 117. Kyowa Hakko Kirin Human Granulocyte Colony-stimulating Factor Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 118. Kyowa Hakko Kirin Human Granulocyte Colony-stimulating Factor Product
Table 119. Kyowa Hakko Kirin Recent Development
Table 120. Sanway Corporation Information
Table 121. Sanway Description and Business Overview
Table 122. Sanway Human Granulocyte Colony-stimulating Factor Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 123. Sanway Human Granulocyte Colony-stimulating Factor Product
Table 124. Sanway Recent Development
Table 125. GenSci Corporation Information
Table 126. GenSci Description and Business Overview
Table 127. GenSci Human Granulocyte Colony-stimulating Factor Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 128. GenSci Human Granulocyte Colony-stimulating Factor Product
Table 129. GenSci Recent Development
Table 130. SL PHARM Corporation Information
Table 131. SL PHARM Description and Business Overview
Table 132. SL PHARM Human Granulocyte Colony-stimulating Factor Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 133. SL PHARM Human Granulocyte Colony-stimulating Factor Product
Table 134. SL PHARM Recent Development
Table 135. Kexing Bioproducts Corporation Information
Table 136. Kexing Bioproducts Description and Business Overview
Table 137. Kexing Bioproducts Human Granulocyte Colony-stimulating Factor Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 138. Kexing Bioproducts Human Granulocyte Colony-stimulating Factor Product
Table 139. Kexing Bioproducts Recent Development
Table 140. Qilu Pharmaceutical Corporation Information
Table 141. Qilu Pharmaceutical Description and Business Overview
Table 142. Qilu Pharmaceutical Human Granulocyte Colony-stimulating Factor Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 143. Qilu Pharmaceutical Human Granulocyte Colony-stimulating Factor Product
Table 144. Qilu Pharmaceutical Recent Development
Table 145. CSPC Corporation Information
Table 146. CSPC Human Granulocyte Colony-stimulating Factor Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 147. CSPC Description and Business Overview
Table 148. CSPC Human Granulocyte Colony-stimulating Factor Product
Table 149. CSPC Recent Development
Table 150. Wuzhong Pharmaceutical Corporation Information
Table 151. Wuzhong Pharmaceutical Human Granulocyte Colony-stimulating Factor Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 152. Wuzhong Pharmaceutical Description and Business Overview
Table 153. Wuzhong Pharmaceutical Human Granulocyte Colony-stimulating Factor Product
Table 154. Wuzhong Pharmaceutical Recent Development
Table 155. Quangang Pharmaceutical Corporation Information
Table 156. Quangang Pharmaceutical Description and Business Overview
Table 157. Quangang Pharmaceutical Human Granulocyte Colony-stimulating Factor Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 158. Quangang Pharmaceutical Human Granulocyte Colony-stimulating Factor Product
Table 159. Quangang Pharmaceutical Recent Development
Table 160. Huabei Pharmaceutical Corporation Information
Table 161. Huabei Pharmaceutical Description and Business Overview
Table 162. Huabei Pharmaceutical Human Granulocyte Colony-stimulating Factor Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 163. Huabei Pharmaceutical Human Granulocyte Colony-stimulating Factor Product
Table 164. Huabei Pharmaceutical Recent Development
Table 165. Harbin Pharmaceutical Corporation Information
Table 166. Harbin Pharmaceutical Description and Business Overview
Table 167. Harbin Pharmaceutical Human Granulocyte Colony-stimulating Factor Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 168. Harbin Pharmaceutical Human Granulocyte Colony-stimulating Factor Product
Table 169. Harbin Pharmaceutical Recent Development
Table 170. Amoytop Biotech Corporation Information
Table 171. Amoytop Biotech Description and Business Overview
Table 172. Amoytop Biotech Human Granulocyte Colony-stimulating Factor Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 173. Amoytop Biotech Human Granulocyte Colony-stimulating Factor Product
Table 174. Amoytop Biotech Recent Development
Table 175. Jiuyuan Gene Engineering Corporation Information
Table 176. Jiuyuan Gene Engineering Description and Business Overview
Table 177. Jiuyuan Gene Engineering Human Granulocyte Colony-stimulating Factor Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 178. Jiuyuan Gene Engineering Human Granulocyte Colony-stimulating Factor Product
Table 179. Jiuyuan Gene Engineering Recent Development
Table 180. Four Rings Biopharmaceutical Corporation Information
Table 181. Four Rings Biopharmaceutical Description and Business Overview
Table 182. Four Rings Biopharmaceutical Human Granulocyte Colony-stimulating Factor Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 183. Four Rings Biopharmaceutical Human Granulocyte Colony-stimulating Factor Product
Table 184. Four Rings Biopharmaceutical Recent Development
Table 185. Production Base and Market Concentration Rate of Raw Material
Table 186. Key Suppliers of Raw Materials
Table 187. Human Granulocyte Colony-stimulating Factor Distributors List
Table 188. Human Granulocyte Colony-stimulating Factor Customers List
Table 189. Human Granulocyte Colony-stimulating Factor Market Trends
Table 190. Human Granulocyte Colony-stimulating Factor Market Drivers
Table 191. Human Granulocyte Colony-stimulating Factor Market Challenges
Table 192. Human Granulocyte Colony-stimulating Factor Market Restraints
Table 193. Research Programs/Design for This Report
Table 194. Key Data Information from Secondary Sources
Table 195. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Granulocyte Colony-stimulating Factor Product Picture
Figure 2. Global Human Granulocyte Colony-stimulating Factor Sales Market Share by Type in 2021 & 2027
Figure 3. 300μg/Dose Product Picture
Figure 4. 150μg/Dose Product Picture
Figure 5. 75μg/Dose Product Picture
Figure 6. Others Product Picture
Figure 7. Global Human Granulocyte Colony-stimulating Factor Sales Market Share by Application in 2021 & 2027
Figure 8. Hospital Examples
Figure 9. Clinic Examples
Figure 10. Global Human Granulocyte Colony-stimulating Factor Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Human Granulocyte Colony-stimulating Factor Sales Growth Rate (2016-2027) & (US$ Million)
Figure 12. Global Human Granulocyte Colony-stimulating Factor Sales (K Units) Growth Rate (2016-2027)
Figure 13. Global Human Granulocyte Colony-stimulating Factor Price Trends Growth Rate (2016-2027) (US$/Unit)
Figure 14. Global Human Granulocyte Colony-stimulating Factor Revenue Market Share by Region: 2016 VS 2021
Figure 15. Global Human Granulocyte Colony-stimulating Factor Revenue Market Share by Region: 2021 VS 2027
Figure 16. North America Human Granulocyte Colony-stimulating Factor Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. North America Human Granulocyte Colony-stimulating Factor Sales (K Units) Growth Rate (2016-2027)
Figure 18. Europe Human Granulocyte Colony-stimulating Factor Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. Europe Human Granulocyte Colony-stimulating Factor Sales (Million USD) Growth Rate (2016-2027)
Figure 20. China Human Granulocyte Colony-stimulating Factor Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. China Human Granulocyte Colony-stimulating Factor Sales (Million USD) and Growth Rate (2016-2027)
Figure 22. Japan Human Granulocyte Colony-stimulating Factor Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Japan Human Granulocyte Colony-stimulating Factor Sales (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Human Granulocyte Colony-stimulating Factor Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Human Granulocyte Colony-stimulating Factor Sales (Million USD) Growth Rate (2016-2027)
Figure 26. India Human Granulocyte Colony-stimulating Factor Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. India Human Granulocyte Colony-stimulating Factor Sales (Million USD) Growth Rate (2016-2027)
Figure 28. Global 5 Largest Human Granulocyte Colony-stimulating Factor Players Market Share by Revenue in Human Granulocyte Colony-stimulating Factor: 2016 & 2020
Figure 29. Human Granulocyte Colony-stimulating Factor Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 30. Global Human Granulocyte Colony-stimulating Factor Revenue Share by Type (2016-2021)
Figure 31. Global Human Granulocyte Colony-stimulating Factor Revenue Growth Rate by Type in 2016 & 2020
Figure 32. Global Human Granulocyte Colony-stimulating Factor Revenue Share by Application (2016-2021)
Figure 33. Global Human Granulocyte Colony-stimulating Factor Revenue Growth Rate by Application in 2016 & 2020
Figure 34. North America Human Granulocyte Colony-stimulating Factor Sales Market Share by Type in 2020
Figure 35. North America Human Granulocyte Colony-stimulating Factor Sales Market Share by Application in 2020
Figure 36. Europe Human Granulocyte Colony-stimulating Factor Sales Market Share by Type in 2020
Figure 37. Europe Human Granulocyte Colony-stimulating Factor Sales Market Share by Application in 2020
Figure 38. China Human Granulocyte Colony-stimulating Factor Sales Market Share by Type in 2020
Figure 39. China Human Granulocyte Colony-stimulating Factor Sales Market Share by Application in 2020
Figure 40. Japan Human Granulocyte Colony-stimulating Factor Sales Market Share by Type in 2020
Figure 41. Japan Human Granulocyte Colony-stimulating Factor Sales Market Share by Application in 2020
Figure 42. Southeast Asia Human Granulocyte Colony-stimulating Factor Sales Market Share by Type in 2020
Figure 43. Southeast Asia Human Granulocyte Colony-stimulating Factor Sales Market Share by Application in 2020
Figure 44. India Human Granulocyte Colony-stimulating Factor Sales Market Share by Type in 2020
Figure 45. India Human Granulocyte Colony-stimulating Factor Sales Market Share by Application in 2020
Figure 46. Key Raw Materials Price Trend
Figure 47. Manufacturing Cost Structure of Human Granulocyte Colony-stimulating Factor
Figure 48. Manufacturing Process Analysis of Human Granulocyte Colony-stimulating Factor
Figure 49. Human Granulocyte Colony-stimulating Factor Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed